<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DC1A2A87-4BDA-4D84-B209-6D8404DCA252"><gtr:id>DC1A2A87-4BDA-4D84-B209-6D8404DCA252</gtr:id><gtr:name>Seoul National University</gtr:name><gtr:address><gtr:line1>Kwanak-Gu</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>The Wolfson Inst for Biomedical Research</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DC1A2A87-4BDA-4D84-B209-6D8404DCA252"><gtr:id>DC1A2A87-4BDA-4D84-B209-6D8404DCA252</gtr:id><gtr:name>Seoul National University</gtr:name><gtr:address><gtr:line1>Kwanak-Gu</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/35D2CF05-BE6B-4818-9EC1-CC28950C98B7"><gtr:id>35D2CF05-BE6B-4818-9EC1-CC28950C98B7</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Nicholas</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901905"><gtr:id>817E2B6D-405B-4586-98AF-BF0EE9271DA1</gtr:id><gtr:title>Peripheral voltage gated sodium channels in health and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901905</gtr:grantReference><gtr:abstractText>The present research proposal focuses on nerves found in the skin muscle and viscera that are the first stage in pathways that cause pain in the brain. In previous studies we have found some key molecules (for example Nav1.7 (a sodium channel protein) that are important pain-killing drug targets in man, by generating mice that have lost genes we think may be important in pain and modelling human disease. Here we show how we can kill different sorts of nerve cells in mice using genetically modified animals and find out what the cells do. By identifying particular cell types and associating them with different aspects of pain, we can the find the molecules that make these cells function, and devise other new pain-killing drugs taht target particular types of pain.</gtr:abstractText><gtr:technicalSummary>Peripheral voltage-gated sodium channels Nav1.7, Nav1.8 and Nav1.9 are interesting analgesic drug targets. We will examine channel protein distribution of expression within and outside the PNS carefully using epitope tags. We will make Bac-Cre transgenic mice for Nav1.7 and Nav1.9 to examine the function and content of cells that express these channels using cell ablation studies (as we did for Nav1.8). We will focus on Nav1.9+ Nav1.8- neurons that seem to be critical for neuropathic pain. We will examine the wiring patterns of defined sets of neurons in normal and chronic pain states. We will develop function blocking monoclonal antibodies for Nav1.7 that may be clinically useful. We will characterise the microRNAs that are essential for sodium channel expression and determine their mechanism of action. We will continue to work with human geneticists to model sodium- channel related pain, and other syndromes.</gtr:technicalSummary><gtr:fund><gtr:end>2016-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1364974</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Seoul National University</gtr:collaboratingOrganisation><gtr:country>Korea, Republic of</gtr:country><gtr:department>Molecular Medicine and Biopharmaceutical Sciences</gtr:department><gtr:description>Collaboration with Seoul National University</gtr:description><gtr:id>5EC5FE52-7532-47F3-8612-B78AB43C6268</gtr:id><gtr:impact>Publicatiosn with Uhtaek Oh

2009 Oh U, Wood JN. Fat location defines sensation Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18435-6. 
2011 Liu M, Oh U, Wood JN. From transduction to pain sensation: defining genes, cells, and circuits. Pain. 2011 Mar;152(3 Suppl):S16-9. 
2012 Cho H, Yang YD, Lee J, Lee B, Kim T, Jang Y, Back SK, Na HS, Harfe BD, Wang F, Raouf R, Wood JN, Oh U. The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons. Nature Neurosci. 2012 May 27;15(7):1015-21. 
2013 Eijkelkamp N., Linley, JE., Torres J.M. , Bee L. , Dickenson A.H.,Gringhuis M. , Minett M.S., Hong G.S., Lee E., Oh U., Ishikawa Y., Zwartkuis F.J. , Cox J.J. , Wood, J.N. A role for Piezo2 in EPAC1-dependent mechanical allodynia Nat Commun. 2013 Apr 9;4:1682.</gtr:impact><gtr:outcomeId>58c28d108566c6.89491286-1</gtr:outcomeId><gtr:partnerContribution>Hosting and provision of a PhD student</gtr:partnerContribution><gtr:piContribution>The BBSRC work enabled me to join the World Class University Programme of Seoul National Universiity for 3 years. We publishedsome joint papers.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Newspaper articles</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>82E05851-F8A2-452A-B2E3-98E5DBF9AD17</gtr:id><gtr:impact>Several articles on our recent studies came out in papers from the Sun to the Times together with international coverage.</gtr:impact><gtr:outcomeId>56d446c2af8a19.50532434</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sanger Centre Pain Conference - The Challenge of Chronic Pain 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CCAEE0FE-7F8C-4CE5-A042-B492FE8FB206</gtr:id><gtr:impact>An International Pain Conference that will be repeated in 2017 at the Sanger Centre</gtr:impact><gtr:outcomeId>56d44545b79667.49850585</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.ucl.ac.uk/wibr/research/research-highlights/pain-conference-2015</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV appearance</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>568B1375-6F15-400B-A785-3C5035BBC164</gtr:id><gtr:impact>Secret world of pain had an audience of 2.5 - 3 million

many letters from public in pain!</gtr:impact><gtr:outcomeId>Fb9E61WUwuw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Conference - Royal Society - Institute of Basic Science Korea</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B7C6F67E-348C-430C-89E0-8E6BC744A1EB</gtr:id><gtr:impact>Very successful first conference - top be followed up in 2015 in the UK with another meeting

UK Korean Government enhanced research collaboration</gtr:impact><gtr:outcomeId>5460a1cb2b8fd9.45934463</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F1B88822-3BE0-4988-993A-FE906D297C02</gtr:id><gtr:impact>A podcast about new developments in treating pain</gtr:impact><gtr:outcomeId>56d445dcbb4008.47024354</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.theguardian.com/science/audio/2016/feb/19/the-end-of-chronic-pain-podcast</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>television show</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5E385D50-C1FB-46BC-9E88-3A4BA721DAE7</gtr:id><gtr:impact>3 million people saw the show on pain

many email contacts followed</gtr:impact><gtr:outcomeId>nnv1U7hSnwG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>650000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>London Pain Consortium</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>JLHRBMR</gtr:fundingRef><gtr:id>AB8FB398-FD21-4914-A79D-E535207BAC2B</gtr:id><gtr:outcomeId>58c28fa91b2101.66517958</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>363000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:fundingRef>H2020-MSCA-ITN-2014-642720</gtr:fundingRef><gtr:id>E00B4759-475F-4DD8-8D2C-8B3E3E7898DE</gtr:id><gtr:outcomeId>58c29055a232f6.97980961</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigator Award</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>101054/Z/13/Z</gtr:fundingRef><gtr:id>61A48608-0860-4CE0-BBBB-9E33DFBAF2A0</gtr:id><gtr:outcomeId>58c29176748c78.28317886</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collaborative Award</gtr:description><gtr:end>2021-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>200183/Z/15/Z</gtr:fundingRef><gtr:id>DA2EDA0F-4595-43DF-8DB8-2E0FE44D6794</gtr:id><gtr:outcomeId>58c290ef350d03.59365115</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present invention relates a pharmaceutical composition comprising (a) an opioid analgesic drug and/or an enkephalinase inhibitor, and (b) a selective Nav1.7 inhibitor.</gtr:description><gtr:grantRef>G0901905</gtr:grantRef><gtr:id>4A806A60-D04F-44E1-99DF-ED454ECB6375</gtr:id><gtr:impact>In progress</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58c28efdb169e4.01634485</gtr:outcomeId><gtr:patentId>wo2015036734</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>SYNERGISTIC COMBINATION OF ANALGESIC DRUGS</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Now more than 20 new mouse lines for pain research</gtr:description><gtr:id>ECB50901-494C-4F92-A3D5-21B568CC8A6D</gtr:id><gtr:impact>Many joint publications - this effort in terms of mouse production continues.</gtr:impact><gtr:outcomeId>MgyXFHg5Xzx</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>many transgenic mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C68DAB6E-3F44-4A42-A88E-A23DDD12DE2B</gtr:id><gtr:title>Sodium channels and mammalian sensory mechanotransduction.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22eac4b8ddda42b2829f487432bb7be4"><gtr:id>22eac4b8ddda42b2829f487432bb7be4</gtr:id><gtr:otherNames>Raouf R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>pm_13513_23_22449024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ED96D4B-82DC-45A1-94DD-8EAE6FF54680</gtr:id><gtr:title>Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db1220f520e731fa5d9b7e6f9901af0"><gtr:id>9db1220f520e731fa5d9b7e6f9901af0</gtr:id><gtr:otherNames>Coste B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13513_23_23487782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DACFA1AD-0C5E-4F16-BE17-EC021B659725</gtr:id><gtr:title>Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bbe7815848afa176a58244fc51b37f3"><gtr:id>1bbe7815848afa176a58244fc51b37f3</gtr:id><gtr:otherNames>Roeckel LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a16b593662c09.64898327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E16E14F9-2284-462F-8A44-8713AD7ACA03</gtr:id><gtr:title>Genetic tracing of Nav1.8-expressing vagal afferents in the mouse.</gtr:title><gtr:parentPublicationTitle>The Journal of comparative neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67d3397b6a871330cbac765e8e49d229"><gtr:id>67d3397b6a871330cbac765e8e49d229</gtr:id><gtr:otherNames>Gautron L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9967</gtr:issn><gtr:outcomeId>pm_13513_23_21618224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2099126-3C63-45DB-AD7A-F03AE6AA22A0</gtr:id><gtr:title>Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>545b4460bdf820.79401281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>598E88AB-F963-4BE2-8C80-85F6DB86DD67</gtr:id><gtr:title>From transduction to pain sensation: defining genes, cells, and circuits.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23f3c52fe5d543eeac44c3179f5ecda0"><gtr:id>23f3c52fe5d543eeac44c3179f5ecda0</gtr:id><gtr:otherNames>Liu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>pm_5435ac85ac83b029e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EC4680A-CEB7-41AA-B0F5-FBA902421E31</gtr:id><gtr:title>Splice variants of Na(V)1.7 sodium channels have distinct ? subunit-dependent biophysical properties.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ccc2d2b825dc095a461ecde19f7dece"><gtr:id>6ccc2d2b825dc095a461ecde19f7dece</gtr:id><gtr:otherNames>Farmer C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13513_23_22911851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>757C86F4-238E-481B-A71F-FAB0D8F28871</gtr:id><gtr:title>The role of Nav1.9 channel in the development of neuropathic orofacial pain associated with trigeminal neuralgia.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c1a2acc4d9c1522e96b2c532c194d34"><gtr:id>4c1a2acc4d9c1522e96b2c532c194d34</gtr:id><gtr:otherNames>Luiz AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>56d441f22a6a57.86607548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA34E6F6-B7C9-4E4A-8C0A-409711C55E11</gtr:id><gtr:title>HDAC4 is required for inflammation-associated thermal hypersensitivity.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b19134fa55e5ff0b5d88484ffb57434"><gtr:id>2b19134fa55e5ff0b5d88484ffb57434</gtr:id><gtr:otherNames>Crow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>565469d30b31d1.94610502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC3E1B0D-35B5-4B1F-9D52-C66B7857FE56</gtr:id><gtr:title>The Yin and Yang of pain: variability in formalin test nociception and morphine analgesia produced by the Yin Yang 1 transcription factor gene.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfac99c86de594583d6149ba81759fd9"><gtr:id>cfac99c86de594583d6149ba81759fd9</gtr:id><gtr:otherNames>Sorge RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>pm_13513_23_23433317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EB5F579-FD64-4858-8B75-682070636F4D</gtr:id><gtr:title>Roles of ASIC3, TRPV1, and NaV1.8 in the transition from acute to chronic pain in a mouse model of fibromyalgia.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13b157efa1b0fb38806f2658a440764b"><gtr:id>13b157efa1b0fb38806f2658a440764b</gtr:id><gtr:otherNames>Chen WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>545b479f737db2.14517716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2013D7C4-AEA3-440C-937C-41FF185B381A</gtr:id><gtr:title>ZBTB20 regulates nociception and pain sensation by modulating TRP channel expression in nociceptive sensory neurons.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c00819eebdc73850ba1a68a578072a30"><gtr:id>c00819eebdc73850ba1a68a578072a30</gtr:id><gtr:otherNames>Ren AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>545b479fa17fb1.51272287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7220ACE-6AAE-411D-80B8-B550B8C1A6BB</gtr:id><gtr:title>The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Pain medicine (Malden, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23f3c52fe5d543eeac44c3179f5ecda0"><gtr:id>23f3c52fe5d543eeac44c3179f5ecda0</gtr:id><gtr:otherNames>Liu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1526-2375</gtr:issn><gtr:outcomeId>hDg76adL7Ad</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87F53C23-EC5A-40A6-80F6-1162F55787F4</gtr:id><gtr:title>Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965cdca89693206fb19f701670e05431"><gtr:id>965cdca89693206fb19f701670e05431</gtr:id><gtr:otherNames>Denk F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d441f1e9b215.10555148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60E353F1-DB50-4631-B569-DAD5DC10E986</gtr:id><gtr:title>Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.</gtr:title><gtr:parentPublicationTitle>Expert opinion on therapeutic targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01ff1d73e3cd6ea16954f9aef519f837"><gtr:id>01ff1d73e3cd6ea16954f9aef519f837</gtr:id><gtr:otherNames>Emery EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-8222</gtr:issn><gtr:outcomeId>57e189817dc739.22475587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD1DD7C9-2CFA-4EF2-A62B-D7234F82BDE7</gtr:id><gtr:title>Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee9c5e67b6d40f0778e53130a97ab23d"><gtr:id>ee9c5e67b6d40f0778e53130a97ab23d</gtr:id><gtr:otherNames>Minett MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d441f181f8a7.26771454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAD73DCA-246F-4757-826C-09A403CF5ECC</gtr:id><gtr:title>Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>pm_13513_23_23292638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A661452-E3B4-4832-81C9-E63121BC5EA4</gtr:id><gtr:title>Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>b3Y4yDkvKJE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57D46436-FB55-4ADE-90E4-50585EC6A78E</gtr:id><gtr:title>Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a07cb8462d0d1fe771f74f6b89119a1c"><gtr:id>a07cb8462d0d1fe771f74f6b89119a1c</gtr:id><gtr:otherNames>Riol-Blanco L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545b470b20a1f6.84068564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AF68D5F-B60D-4917-996A-3D20871F96E7</gtr:id><gtr:title>Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce3a3e72d2229b0fa33500c7ccc94999"><gtr:id>ce3a3e72d2229b0fa33500c7ccc94999</gtr:id><gtr:otherNames>Waxman SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>54609fb166c1c4.13464971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>075B1E24-11E4-4059-846C-41FA423F7B46</gtr:id><gtr:title>The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9324f62c3d0034c69aab0c07c81fe25"><gtr:id>e9324f62c3d0034c69aab0c07c81fe25</gtr:id><gtr:otherNames>Sexton JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>565469d37e8ce4.93484624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F195A79C-06D6-4C49-96E4-4D8E8E21CA9C</gtr:id><gtr:title>TRPs and pain.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9324f62c3d0034c69aab0c07c81fe25"><gtr:id>e9324f62c3d0034c69aab0c07c81fe25</gtr:id><gtr:otherNames>Sexton JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>545b446136b331.66026811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A98A38CE-AC72-49FE-A075-7F483CFF48E5</gtr:id><gtr:title>Loss-of-function mutations in sodium channel Nav1.7 cause anosmia.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcc3701ae7470a3241276fbc611a409d"><gtr:id>dcc3701ae7470a3241276fbc611a409d</gtr:id><gtr:otherNames>Weiss J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_13513_23_21441906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90F293B1-9585-4D93-9476-1A83EF25184F</gtr:id><gtr:title>Noxious mechanosensation - molecules and circuits.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545704157c3b86379376f29ea8d635ca"><gtr:id>545704157c3b86379376f29ea8d635ca</gtr:id><gtr:otherNames>Wood JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn><gtr:outcomeId>pm_13513_23_22056025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2122C183-1E2F-4538-A5A0-F6E20B7CAFB5</gtr:id><gtr:title>Sodium Channels in Pain and Cancer: New Therapeutic Opportunities.</gtr:title><gtr:parentPublicationTitle>Advances in pharmacology (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c1a2acc4d9c1522e96b2c532c194d34"><gtr:id>4c1a2acc4d9c1522e96b2c532c194d34</gtr:id><gtr:otherNames>Luiz AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1054-3589</gtr:issn><gtr:outcomeId>56d441f15465b2.13690917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65F9F90C-5AD3-4D28-B3B1-7BCC2F589997</gtr:id><gtr:title>Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcd14be04f6653c50e2c70f7b99f0186"><gtr:id>bcd14be04f6653c50e2c70f7b99f0186</gtr:id><gtr:otherNames>Lau J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>pm_13513_23_22188729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F109BB7A-2FAC-4F9E-AB55-777D99172278</gtr:id><gtr:title>The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c0c5a8a1425dc89bd73c77011a2d2aa"><gtr:id>9c0c5a8a1425dc89bd73c77011a2d2aa</gtr:id><gtr:otherNames>Cho H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_13513_23_22634729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16B5564D-270E-4EDE-96B8-C2F0BF78C202</gtr:id><gtr:title>Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee9c5e67b6d40f0778e53130a97ab23d"><gtr:id>ee9c5e67b6d40f0778e53130a97ab23d</gtr:id><gtr:otherNames>Minett MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_13513_23_22531176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C94E0CC-AFDE-4D69-BCA7-168BDE53551B</gtr:id><gtr:title>GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_13513_23_20147541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0121468-BAB4-40F6-BD7E-FCD609FE095F</gtr:id><gtr:title>Multiple postnatal craniofacial anomalies are characterized by conditional loss of polycystic kidney disease 2 (Pkd2).</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53ebda0ef1d5f34531df76cc3306c305"><gtr:id>53ebda0ef1d5f34531df76cc3306c305</gtr:id><gtr:otherNames>Khonsari RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13513_23_23390131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7EDC400-23D1-4F10-9A86-003C0632E932</gtr:id><gtr:title>Glycine at the gate--from model to mechanism.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11e74e5a3a7b3794a49aa81194f3c27f"><gtr:id>11e74e5a3a7b3794a49aa81194f3c27f</gtr:id><gtr:otherNames>Zhao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>565469d2b0bb12.96967302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FD39837-FA86-499E-98B2-3396C8B68713</gtr:id><gtr:title>G protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signaling.</gtr:title><gtr:parentPublicationTitle>Molecular medicine (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1076-1551</gtr:issn><gtr:outcomeId>pm_13513_23_22331028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72C1B611-7ED7-4224-8F2E-B5B0E6CB5DF6</gtr:id><gtr:title>Null mutation in SCN9A in which noxious stimuli can be detected in the absence of pain.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e4878389642910b2d3b2db93ee77f8"><gtr:id>50e4878389642910b2d3b2db93ee77f8</gtr:id><gtr:otherNames>Ramirez JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54609fb13cd936.97183084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BB4593B-458B-4CE1-9B30-69BE5D1BB764</gtr:id><gtr:title>The &amp;quot;Pain Matrix&amp;quot; in Pain-Free Individuals.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c316221b20c66c8cc8a05d1ae53c6f77"><gtr:id>c316221b20c66c8cc8a05d1ae53c6f77</gtr:id><gtr:otherNames>Salomons TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>57e18981a18bf2.18914186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1508899-2F1A-4A62-9851-8505748385BC</gtr:id><gtr:title>No pain, more gain.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47d52ce5cf737af5897ceb23de3e4447"><gtr:id>47d52ce5cf737af5897ceb23de3e4447</gtr:id><gtr:otherNames>Cox JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13513_23_24165728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D4C8150-76E2-4C0B-8A23-268865B00B5D</gtr:id><gtr:title>The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a2b7f8e70a0674f12b23e2abfeb5499"><gtr:id>7a2b7f8e70a0674f12b23e2abfeb5499</gtr:id><gtr:otherNames>Werdehausen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>565469d331be09.56381056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61D0BE61-5110-44C4-B4E4-CC782768FF77</gtr:id><gtr:title>Mechanical allodynia.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b5ac02910fd0038e6d84bac9c361824"><gtr:id>2b5ac02910fd0038e6d84bac9c361824</gtr:id><gtr:otherNames>Lolignier S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn><gtr:outcomeId>54609fb0e586e8.97329510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8389985B-8C65-485A-BCF1-02FB83EBD7C0</gtr:id><gtr:title>The Low-Threshold Calcium Channel Cav3.2 Determines Low-Threshold Mechanoreceptor Function.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78a98ec1a8afe212f74297b18ee09686"><gtr:id>78a98ec1a8afe212f74297b18ee09686</gtr:id><gtr:otherNames>Fran?ois A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>565469d23990c9.43296895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>067ED8E7-49A9-407E-A238-65F8F3343E79</gtr:id><gtr:title>Kinetic properties of mechanically activated currents in spinal sensory neurons.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed844d05fc1e01d211d5eb3e0a2581c"><gtr:id>eed844d05fc1e01d211d5eb3e0a2581c</gtr:id><gtr:otherNames>Rugiero F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>pm_13513_13_19948656</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81492D81-1691-45A0-AADC-3EA1C14D836D</gtr:id><gtr:title>The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de5d7e716a008f06f9212714d7dd55c6"><gtr:id>de5d7e716a008f06f9212714d7dd55c6</gtr:id><gtr:otherNames>Choi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>565469d25dc1f5.38016482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>683B7A25-E552-4E37-95AF-7BC4B93E7916</gtr:id><gtr:title>MicroRNA-1-associated effects of neuron-specific brain-derived neurotrophic factor gene deletion in dorsal root ganglia.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5049d2204603b8717af953c2e450ec5"><gtr:id>a5049d2204603b8717af953c2e450ec5</gtr:id><gtr:otherNames>Neumann E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>57e189820326d3.96351846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1CF2EA4-F9AD-4C3F-A626-44FC33407792</gtr:id><gtr:title>Pain as a channelopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22eac4b8ddda42b2829f487432bb7be4"><gtr:id>22eac4b8ddda42b2829f487432bb7be4</gtr:id><gtr:otherNames>Raouf R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>LfaSGvNbA3W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1492785-B53D-42EC-819C-59328387CBC8</gtr:id><gtr:title>Transient receptor potential channels and mechanosensation.</gtr:title><gtr:parentPublicationTitle>Annual review of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0147-006X</gtr:issn><gtr:outcomeId>pm_13513_23_23750514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDBD3DB7-B88F-4E8E-8AA6-3B341D1D203F</gtr:id><gtr:title>Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baa2ea7f1dbc24f0907f9f104ac47691"><gtr:id>baa2ea7f1dbc24f0907f9f104ac47691</gtr:id><gtr:otherNames>Koenig J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>565469d353c010.19129905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28417522-F086-4D82-9F1F-F9ECA7C09639</gtr:id><gtr:title>Genetic variation in SCN10A influences cardiac conduction.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6331e598a783832f88337f69a52dc44"><gtr:id>a6331e598a783832f88337f69a52dc44</gtr:id><gtr:otherNames>Chambers JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13513_23_20062061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EF6F8DB-0E92-40D1-AB61-0576FDA80B2D</gtr:id><gtr:title>Pain without nociceptors? Nav1.7-independent pain mechanisms.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee9c5e67b6d40f0778e53130a97ab23d"><gtr:id>ee9c5e67b6d40f0778e53130a97ab23d</gtr:id><gtr:otherNames>Minett MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>pm_13513_23_24440715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27961E22-9CE5-484F-B3CC-A2DAE7C6E26D</gtr:id><gtr:title>Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b68af11d30644162302937a84a0bda7"><gtr:id>6b68af11d30644162302937a84a0bda7</gtr:id><gtr:otherNames>Weibel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13513_23_24069332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CEA8618-27E0-4E33-B5A5-CB5C217BB4A5</gtr:id><gtr:title>Significant determinants of mouse pain behaviour.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee9c5e67b6d40f0778e53130a97ab23d"><gtr:id>ee9c5e67b6d40f0778e53130a97ab23d</gtr:id><gtr:otherNames>Minett MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545b4460e31908.59618824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A41FBE4E-2F3C-42C7-8F70-F2817CAB0287</gtr:id><gtr:title>Neurological perspectives on voltage-gated sodium channels.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13513_23_22961543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32017BFE-585D-4C18-8875-FB42002D6BEB</gtr:id><gtr:title>Na(v)1.8 channelopathy in mutant mice deficient for myelin protein zero is detrimental to motor axons.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e62ebdea2e4804d578e63af27e1cf78"><gtr:id>7e62ebdea2e4804d578e63af27e1cf78</gtr:id><gtr:otherNames>Moldovan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>NBaTJYAEx5H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05C13220-6177-4524-BAE4-A86C23F2ACC9</gtr:id><gtr:title>The Genetics of Pain: Implications for Therapeutics.</gtr:title><gtr:parentPublicationTitle>Annual review of pharmacology and toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9324f62c3d0034c69aab0c07c81fe25"><gtr:id>e9324f62c3d0034c69aab0c07c81fe25</gtr:id><gtr:otherNames>Sexton JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0362-1642</gtr:issn><gtr:outcomeId>5a16b59312e845.09221364</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76BDA5FD-EE93-45F6-91FE-9F424C70B490</gtr:id><gtr:title>VGLUT2-dependent sensory neurons in the TRPV1 population regulate pain and itch.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3a6602e21704a5beeebc61fa2c9f3a"><gtr:id>5a3a6602e21704a5beeebc61fa2c9f3a</gtr:id><gtr:otherNames>Lagerstr?m MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>oHGCA3gknMh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9436615-871D-494E-BDFF-50C5C7DE6455</gtr:id><gtr:title>Multiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease-derived stimuli.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944f732b742471f31e1acd0ec6bc9ae7"><gtr:id>944f732b742471f31e1acd0ec6bc9ae7</gtr:id><gtr:otherNames>Hockley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>545b446114ebf4.10688932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1605AE37-7547-418A-AC2C-3ECF7134FF40</gtr:id><gtr:title>A sensory subpopulation depends on vesicular glutamate transporter 2 for mechanical pain, and together with substance P, inflammatory pain.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3a6602e21704a5beeebc61fa2c9f3a"><gtr:id>5a3a6602e21704a5beeebc61fa2c9f3a</gtr:id><gtr:otherNames>Lagerstr?m MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13513_23_21415372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B29A376-E5AB-43D5-AD57-5E4B23EB2B41</gtr:id><gtr:title>Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11e74e5a3a7b3794a49aa81194f3c27f"><gtr:id>11e74e5a3a7b3794a49aa81194f3c27f</gtr:id><gtr:otherNames>Zhao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_5435ac95ac92e1a45</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>451BDBAB-1BFB-4077-B2A6-F491065FB276</gtr:id><gtr:title>From plant extract to molecular panacea: a commentary on Stone (1763) 'An account of the success of the bark of the willow in the cure of the agues'.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545704157c3b86379376f29ea8d635ca"><gtr:id>545704157c3b86379376f29ea8d635ca</gtr:id><gtr:otherNames>Wood JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>565469d2869926.50973781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC0313A6-ADC3-447E-820E-4B6611F57863</gtr:id><gtr:title>Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aeed9d7d05ae7b524ca6c8b08156149"><gtr:id>4aeed9d7d05ae7b524ca6c8b08156149</gtr:id><gtr:otherNames>Isensee J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>5a16b593dbed50.68052718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3D21786-864E-4801-BF04-52DB7502C1BF</gtr:id><gtr:title>Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92d42e9f3381b30adfb0a33afcbf8af7"><gtr:id>92d42e9f3381b30adfb0a33afcbf8af7</gtr:id><gtr:otherNames>Gaveriaux-Ruff C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>G9yzgDkJ4yR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>681C42FA-EC86-4D32-99E5-B2CBA0E92E3F</gtr:id><gtr:title>A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25ade2c021da81e3dd342516d183a560"><gtr:id>25ade2c021da81e3dd342516d183a560</gtr:id><gtr:otherNames>Kremeyer B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>pm_13513_23_20547126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE68E5F0-0D00-402B-B8BD-C6769913A5D4</gtr:id><gtr:title>Na+ current properties in islet a- and ?-cells reflect cell-specific Scn3a and Scn9a expression.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/249808295c23f4d85591d33c08cc2225"><gtr:id>249808295c23f4d85591d33c08cc2225</gtr:id><gtr:otherNames>Zhang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>54609fb1163ff2.78415661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0B4A5B1-6B02-4B20-A7B1-647D57325EC5</gtr:id><gtr:title>TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d71f0e8d4c37a25f5cde660579fb11a"><gtr:id>7d71f0e8d4c37a25f5cde660579fb11a</gtr:id><gtr:otherNames>Quick K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_13513_23_22724068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83CED429-C9B2-4CC4-A28D-24B50DF279DA</gtr:id><gtr:title>Sodium channels and pain.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b376d10bfb8c4c22a03eb295b788e59"><gtr:id>2b376d10bfb8c4c22a03eb295b788e59</gtr:id><gtr:otherNames>Habib AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>565469d2d56252.06949300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8632501-0478-4287-9EE0-5D81D4474897</gtr:id><gtr:title>Piezo2 is the major transducer of mechanical forces for touch sensation in mice.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0c81d8fa9ca58333bc432f51b8d3df4"><gtr:id>e0c81d8fa9ca58333bc432f51b8d3df4</gtr:id><gtr:otherNames>Ranade SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>565469d209fba1.36357586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DF3F2F6-2DA1-4AC1-BDBC-807B2B8B5430</gtr:id><gtr:title>Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7c331da82ab650a70c991b76c89001f"><gtr:id>b7c331da82ab650a70c991b76c89001f</gtr:id><gtr:otherNames>Vetter I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_13513_23_22850668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C51D689B-6CCE-449A-8EA4-CC63388ABD7A</gtr:id><gtr:title>Nerve growth factor and pain.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545704157c3b86379376f29ea8d635ca"><gtr:id>545704157c3b86379376f29ea8d635ca</gtr:id><gtr:otherNames>Wood JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_13513_23_20942675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F45334FB-B6E8-48F3-8641-6777EB6D5428</gtr:id><gtr:title>Nociceptor-expressed ephrin-B2 regulates inflammatory and neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11e74e5a3a7b3794a49aa81194f3c27f"><gtr:id>11e74e5a3a7b3794a49aa81194f3c27f</gtr:id><gtr:otherNames>Zhao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>pm_13513_23_21059214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D32E407-392F-486B-B226-DB8A39B14677</gtr:id><gtr:title>A role for Piezo2 in EPAC1-dependent mechanical allodynia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_13513_23_23575686</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901905</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>